Skip to main content Skip to navigation
Hamburger Menu
Search icon
Order lookup icon Order lookup icon
Order Lookup
Country Selector Country Selector
Canada (English)
Profile Icon Profile Icon
Sign-in/Register UserName
Products

Solutions

Discover & Learn

Resources & Tools

Support

Search icon Search icon
Close Menu
      Alert Icon
      PE Rat Anti-Human IL-5
      PE Rat Anti-Human IL-5
      Detection of IL-5 expression by stimulated human CD4+ T cells. Isolated human CD4+ cells were stimulated with immobilized anti-human CD3 (1 µg/ml final concentration; UCHT1, Cat. No. 555329), soluble anti-human CD28.2 antibody (20 ng/ml final concentration; Cat. No. 555725), recombinant human IL-2 (10 ng/ml final concentration; Cat. No. 555605) and recombinant human IL-4 (10 ng/ml final concentration; Cat. No. 554603) for 2 days. The cells were subsequently cultured in medium containing recombinant human IL-2 and recombinant human IL-4 for 3 days. The cells were then harvested and restimulated for 6 hours with PMA (Sigma, Cat. #P-8139) and calcium ionophore A23187 (Sigma, Cat. #C-9275) in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). Finally, the cells were harvested, stained with 0.25 µg of PE-Cy5-anti-CD4 (PE-Cy5-RPA-T4, Cat. No. 555348), fixed, permeabilized, and subsequently stained with 20 µl PE-conjugated rat anti-human IL-5 (PE-JES1-39D10, Cat. No. 559332) by following the usage section above and  Pharmingen's staining protocol (left panel). To demonstrate specificity of staining, the binding of PE-JES1-39D10 antibody was blocked by the preincubation of the conjugated antibody with recombinant human IL-5 (0.1 µg; Cat. No. 554606; middle panel), and by preincubation of the fixed/permeabilized cells with unlabeled JES1-39D10 antibody (5 µg/Cat. No. 554487; right panel) prior to staining with the PE-JEs1-39D10 antibody. The quadrant markers for the bivariate dot plots were set based on the autofluorescence control and verified with the recombinant cytokine blocking and unlabeled blocking specificity controls.
      PE Rat Anti-Human IL-5
      Detection of IL-5 expression by stimulated human CD4+ T cells. Isolated human CD4+ cells were stimulated with immobilized anti-human CD3 (1 µg/ml final concentration; UCHT1, Cat. No. 555329), soluble anti-human CD28.2 antibody (20 ng/ml final concentration; Cat. No. 555725), recombinant human IL-2 (10 ng/ml final concentration; Cat. No. 555605) and recombinant human IL-4 (10 ng/ml final concentration; Cat. No. 554603) for 2 days. The cells were subsequently cultured in medium containing recombinant human IL-2 and recombinant human IL-4 for 3 days. The cells were then harvested and restimulated for 6 hours with PMA (Sigma, Cat. #P-8139) and calcium ionophore A23187 (Sigma, Cat. #C-9275) in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). Finally, the cells were harvested, stained with 0.25 µg of PE-Cy5-anti-CD4 (PE-Cy5-RPA-T4, Cat. No. 555348), fixed, permeabilized, and subsequently stained with 20 µl PE-conjugated rat anti-human IL-5 (PE-JES1-39D10, Cat. No. 559332) by following the usage section above and  Pharmingen's staining protocol (left panel). To demonstrate specificity of staining, the binding of PE-JES1-39D10 antibody was blocked by the preincubation of the conjugated antibody with recombinant human IL-5 (0.1 µg; Cat. No. 554606; middle panel), and by preincubation of the fixed/permeabilized cells with unlabeled JES1-39D10 antibody (5 µg/Cat. No. 554487; right panel) prior to staining with the PE-JEs1-39D10 antibody. The quadrant markers for the bivariate dot plots were set based on the autofluorescence control and verified with the recombinant cytokine blocking and unlabeled blocking specificity controls.
      Product Details
      Down Arrow Up Arrow


      BD Pharmingen™
      Human (QC Testing)
      Rat IgG2a
      Recombinant human IL-5
      Intracellular staining (flow cytometry) (Routinely Tested)
      20 µl
      AB_397229
      Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
      RUO


      Preparation And Storage

      The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with R-PE under optimum conditions, and unconjugated antibody and free PE were removed. Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
      Show More blue down arrow Show Less blue up arrow

      Recommended Assay Procedures

      Immunofluorescent Staining and Flow Cytometric Analysis: The JES1-39D10 antibody is useful for immunofluorescent staining and flow cytometric analysis to identify and enumerate human IL-5 producing cells within mixed cell populations. The PE-conjugated JES1-39D10 antibody is especially suitable for these experiments (see Figure). This 100 Test Size formulation of the PE-conjugated JES1-39D10 antibody has been pretitrated to assure effective intracellular detection of human IL-5 using 20 µl/1 x 10e6 cells. For specific methodology, please visit our web site, www.bdbiosciences.com, and go to the protocols section or the chapter on intracellular staining in the Immune Function Handbook.

      A useful control for demonstrating specificity of staining is either of the following: 1) pre-block the PE-JES1-39D10 antibody with excess ligand (e.g., human IL-5, Cat. No. 554606) prior to staining, or 2) pre-block paraformaldehyde-fixed/saponin-permeabilized cells with unlabeled JES1-39D10 antibody (e.g., Cat. No. 554488) prior to staining. The intracellular staining technique and use of blocking controls are described in detail by C. Prussin and D. Metcalfe. A suitable rat IgG2a isotype control for assessing the level of background staining on paraformaldehyde-fixed/saponin-permeabilized mouse or human cells is also available in a 100 Test Size formulation PE-R35-95 (Cat. No. 559317).

      Important Note: This pretitered antibody solution does not contain a cell permeabilization agent. It is necessary to include a cell permeabilization agent when using the pre-titered antibody solution to stain fixed and permeabilized cells. Perm/Wash™ Buffer (Cat. No. 554723) contains the permeabilization agent saponin and is useful for this purpose as described in the Usage section.

      USAGE

      1.   Resuspend 1 x 10e6 fixed and permeabilized cells in 20 µl of the pre-titered antibody solution and 30 µl of 1X Perm/Wash™ Buffer (Cat. No. 554723).

      2.   Incubate the cell suspension for 15 minutes (at room temperature or 4°C).

      3.   Wash twice in 100 µl of 1X Perm/Wash™ Buffer (Cat. No. 554723).

      Show More blue down arrow Show Less blue up arrow

      Product Notices

      1. This reagent has been pre-diluted for use at the recommended Volume per Test. We typically use 1 × 10^6 cells in a 100-µl experimental sample (a test).
      2. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
      3. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
      4. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
      5. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
      6. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
      Show More blue down arrow Show Less blue up arrow
      559332 Rev. 2
      Antibody Details
      Down Arrow Up Arrow
      JES1-39D10

      The JES1-39D10 antibody reacts with human interleukin-5 (IL-5). The immunogen used to generate the JES1-39D10 hybridoma was COS-expressed recombinant human IL-5. This is a neutralizing antibody.

      559332 Rev. 2
      Format Details
      Down Arrow Up Arrow
      PE
      R-Phycoerythrin (PE), is part of the BD family of Phycobiliprotein dyes. This fluorochrome is a multimeric fluorescent phycobiliprotein with excitation maximum (Ex Max) of 496 nm and 566 nm and an emission maximum (Em Max) at 576 nm. PE is designed to be excited by the Blue (488 nm), Green (532 nm) and Yellow-Green (561 nm) lasers and detected using an optical filter centered near 575 nm (e.g., a 575/26-nm bandpass filter). As PE is excited by multiple lasers, this can result in cross-laser excitation and fluorescence spillover on instruments with various combinations of Blue, Green, and Yellow-Green lasers. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.
      altImg
      PE
      Yellow-Green 488 nm, 532 nm, 561 nm
      496 nm, 566 nm
      576 nm
      559332 Rev.2
      Citations & References
      Down Arrow Up Arrow
      View product citations for antibody "559332" on CiteAb

      Development References (7)

      1. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev. 1992; 127:5-24. (Clone-specific: ELISA). View Reference
      2. Abrams JS, Silver JE, Van Dyke RE, Gleich GI. Eosinophil-active cytokines in human disease: development and use of monoclonal antibodies to IL-3, IL-5 and GMCSF. In: Gleich GJ and Kay AB, ed. Eosinophils in Allergy and Inflammation. New York: Dekker; 1994:133-157.
      3. Butterfield JH, Leiferman KM, Abrams J, et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood. 1992; 79(3):688-692. (Clone-specific). View Reference
      4. Elson LH, Nutman TB, Metcalfe DD, Prussin C. Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation. J Immunol. 1995; 154(9):4294-4301. (Clone-specific: Flow cytometry). View Reference
      5. Jung T, Schauer U, Rieger C, et al. Interleukin-4 and interleukin-5 are rarely co-expressed by human T cells. Eur J Immunol. 1995; 25(8):2413-2416. (Clone-specific: Flow cytometry). View Reference
      6. Limaye AP, Abrams JS, Silver JE, et al. Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis. J Clin Invest. 1991; 88(4):1418-1421. (Clone-specific). View Reference
      7. Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods. 1995; 188(1):117-128. (Methodology: IC/FCM Block). View Reference
      View All (7) View Less
      559332 Rev. 2

      Please refer to Support Documents for Quality Certificates


      Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


      Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

      For Research Use Only. Not for use in diagnostic or therapeutic procedures.